The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial-Reference-Cited by-同舟云学术

The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial

Published:2000-05 Issue:7 Volume:14 Page:781-789
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Katlama Christine,Clotet Bonaventura,Plettenberg Andreas,Jost Josef,Arasteh Keikawus,Bernasconi Enos,Jeantils Vincent,Cutrell Amy,Stone Chris,Ait-Khaled Mounir,Purdon Scott

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference7 articles.

1. 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity

2. Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89

3. Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults

4. Potential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination Therapy

5. Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRF08_BC subtype is more prone to ART failure and new-generation NNRTI-resistance under long-term first-line ART;International Journal of Antimicrobial Agents;2024-08

2. The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical review;Antiviral Therapy;2023-05-22

3. Abacavir adverse reactions related with HLA-B*57:01 haplotype in a large cohort of patients infected with HIV;Pharmacogenetics and Genomics;2020-05-22

4. Machine Learning to Improve the Effectiveness of ANRS in Predicting HIV Drug Resistance;Healthcare Informatics Research;2017

5. Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: results from the VERITAS study (TMC114HIV4054);HIV Clinical Trials;2015-05